Skip to main content

and
  1. Article

    Author Correction: Systems vaccinology of the BNT162b2 mRNA vaccine in humans

    Prabhu S. Arunachalam, Madeleine K. D. Scott, Thomas Hagan, Chunfeng Li in Nature (2023)

  2. Article

    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine

    Despite the success of the BNT162b2 mRNA vaccine, the immunological mechanisms that underlie its efficacy are poorly understood. Here we analyzed the innate and adaptive responses to BNT162b2 in mice, and show...

    Chunfeng Li, Audrey Lee, Lilit Grigoryan, Prabhu S. Arunachalam in Nature Immunology (2022)

  3. Article

    Open Access

    A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice

    Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity ...

    Audrey Lee, Madeleine K. D. Scott, Florian Wimmers in Nature Communications (2022)

  4. Article

    Systems vaccinology of the BNT162b2 mRNA vaccine in humans

    The emergency use authorization of two mRNA vaccines in less than a year from the emergence of SARS-CoV-2 represents a landmark in vaccinology1,2. Yet, how mRNA vaccines stimulate the immune system to elicit prot...

    Prabhu S. Arunachalam, Madeleine K. D. Scott, Thomas Hagan, Chunfeng Li in Nature (2021)

  5. Article

    Open Access

    T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers

    Recent efforts toward an HIV vaccine focus on inducing broadly neutralizing antibodies, but eliciting both neutralizing antibodies (nAbs) and cellular responses may be superior. Here, we immunized macaques wit...

    Prabhu S. Arunachalam, Tysheena P. Charles, Vineet Joag in Nature Medicine (2020)